Interestingly, we determined that Msi1 KO cells are more sensitive to Triapine and Olaparib and a synergistic effect was observed when we treated glioblastoma cells with Olaparib and Luteolin, a Msi1 inhibitor [7]. This evidence concerns the gene MSI1 and glioblastoma.